163 episodes

A weekly conversation with the innovators who will change how health care is delivered.

Medtech Talk Healthegy

    • Business

A weekly conversation with the innovators who will change how health care is delivered.

    Episode 162: Bernie Haffey on Cutting Through to High Performance

    Episode 162: Bernie Haffey on Cutting Through to High Performance

    Bernie Haffey started his career as a high school physics teacher, then decided to go to business school. He remained interested in science and technology though, so he started working in the medtech industry at Hewlett-Packard’s Medical Products Group before transferring to Mentor Corp. After rising in the ranks at Mentor, Bernie then joined Summit Technology, where he was first exposed to the concept of high-performance management systems. He learned about the importance of a clear vision (and vision statement), the value of a mission statement and how it differs from a vision, and the benefit of narrowing a multitude of initiatives down to the vital few that focus on true breakthrough opportunities. After over two decades of experience as a senior leader at Summit, Intralase, NDO Surgical, and Nexis Vision, Bernie decided to return to his roots, found a consulting firm focused on high-performance management systems, and start teaching management science. In this interview with host Geoff Pardo, Bernie shares many of the critical aspects, decision points, and challenges of high-performance management systems, including how to balance voices of the customer, shareholder, and employee; the importance of a strong operational team who can carry out a new vision; the need for effective systems in addition to brilliant staff; and many of the watchouts when leading change in an organization.

    • 1 hr 7 min
    Episode 161: Amar Sawhney on Finding the Right Chemistry for Entrepreneurial Success

    Episode 161: Amar Sawhney on Finding the Right Chemistry for Entrepreneurial Success

    Now a seasoned medtech entrepreneur and leader, Amar Sawhney first became interested in the industry starting in graduate school. He was studying chemical engineering and developing biodegradable polymers for adhesion prevention and hydrogels for light-activated polymerization within the body. He and his advisor were then approached by Mayfield Fund to spin out the technology into the startup Focal. Amar was fortunate to learn a lot from then CEO Mark Levin, including some hard lessons that drove him and Fred Khosravi to found Incept, an IP holding company for creating operating companies based on field of use. As CEO/Founder of Confluent Surgical, AccessClosure, Augmenix, Ocular Therapeutix, and now Instylla, Amar learned how to transition from scientist to executive and is truly a medtech influencer. In this interview with host Geoff Pardo, Amar shares many of the valuable lessons he’s learned founding and managing various startups, including how to find the right application for a technology, when a platform solution really makes sense, how to effectively lead and build successful teams, the value of a diverse workforce, and tips for overcoming the funding gap for early-stage companies, plus his candid thoughts on the differences in funding/entrepreneurship between the East and West coasts.

    Amarpreet (Amar) Sawhney, Ph.D., is the Founder, Chief Executive Officer and Chairman of the Board of Directors of Instylla. He is also the CEO of Pramand LLC, and Rejoni, Inc. Prior to this Dr. Sawhney served as CEO and Chairman of Augmenix (acquired by Boston Scientific) and Ocular Therapeutix (NASDAQ: OCUL). In addition, he is a general partner of Incept, LLC, an intellectual property holding company. Previously, Dr. Sawhney founded Confluent Surgical and served as its President and CEO prior to its acquisition by Covidien plc. He also was a technology founder of Focal, Inc., a biopharmaceutical company acquired by Genzyme Corporation, and a founder of AccessClosure, Inc., acquired by Cardinal Health. Dr. Sawhney’s innovations are the subject of over 120 issued and pending patents. He holds M.S. and Ph.D. degrees in chemical engineering from the University of Texas at Austin, as well as a B.Tech. in chemical engineering from the Indian Institute of Technology, Delhi India.

    • 1 hr 5 min
    Episode 160: Securing Coverage and Payment for Your Innovative Medical Device: Advice from the Experts

    Episode 160: Securing Coverage and Payment for Your Innovative Medical Device: Advice from the Experts

    Navigating the ever-changing sea of medtech reimbursement is never easy, particularly with the recent swings in policies pertaining to breakthrough devices. As part of the continued Medtech Talk Digital Discussion Series, host Geoff Pardo moderates a panel interview with three medtech reimbursement experts to look at strategies for obtaining reimbursement coding, coverage, and payment: Mary Hailey, CCM, CDMS, Vice President Health Economics and Reimbursement, Relievant Medsystems, Inc.; DeChane Dorsey, JD, Executive Director of AdvaMed Accel, AdvaMed; and David Gregory, Principal, Healthcare & Life Sciences Consulting Leader, Baker Tilly. The panel discusses coding and payment issues that are particularly pertinent to small/mid-sized companies; the impact of recent changes to accommodate breakthrough devices, including MCIT, Add-On payment, NTAP, and TPT; CMS’s approach to handling issues/questions and how to best work with the agency; thinking wholistically about bringing your product to market (more than just FDA approval); and the influence of advocacy efforts by physician specialty societies on coding and payments. Listen now to catch these valuable insights!

    Mary Hailey, CCM, CDMS, Vice President Health Economics and Reimbursement, Relievant Medsystems, Inc. DeChane Dorsey, JD, Executive Director of AdvaMed Accel, AdvaMed David Gregory, Principal, Healthcare & Life Sciences Consulting Leader, Baker Tilly

    • 1 hr 4 min
    Episode 159: Lessons from Medtech Leader and Mentor Joe Mandato

    Episode 159: Lessons from Medtech Leader and Mentor Joe Mandato

    There’s nothing like those pivotal moments of a startup that lead to it becoming wildly successful. The excitement as the company’s first product begins to earn market share and attention from additional investors or acquirers. This month’s podcast guest Joe Mandato has been in that situation with several successful startups turned corporations, including Guidant Corporation, Origin Medical Systems (predecessor of Intuitive Surgical), and Align Technology (maker of InvisAlign), as well as leading Tear Science and iOptics Research. Joe has learned a lot about leadership throughout these endeavors and his doctoral research on the effectiveness of corporate governance. He’s seen firsthand the importance of understanding where leaders can contribute and where they need help; switching from the “wrong” application to the “right” one; having technological innovation at root, but the right business model innovation and culture to achieve to success; and maximizing boards of directors. After many decades in the industry, Joe is truly a medtech mentor. In this interview with host Geoff Pardo, Joe shares many of the valuable lessons he’s learned working with various startups, how to shift from being an operator to an investor, how to best leverage boards and board meetings, and his suggestions for changes in the healthcare system and opportunities coming out of COVID.

    Joe Mandato holds a Doctor of Business Administration degree from Case Western Reserve University, where his research focused on the evolving role of boards in ensuring effective corporate governance. He was a 2011-2012 Fellow of Harvard University’s Advanced Leadership Initiative and served as Co-Chair of Harvard’s Advanced Leadership Coalition. He is a Managing Director at DeNovo Ventures, Senior Advisor at Apercen Partners and Sonder Capital and Lecturer at Stanford University. He has served on more than 20 public and private boards of directors focused on technology and the life sciences. He also serves on the boards of Case Western Reserve University, Headstart and Save the Children. He was an investor, board member and advisor to the founders of Align Technologies (Invisalign) and has served as CEO of five life sciences companies, which created significant shareholder value. He was a member of the founding management committee of Guidant Corporation (NYSE) and was an entrepreneur-in-residence at Mayfield Fund, a Silicon Valley venture fund. He has authored or co-authored numerous articles on healthcare and governance and the book The Entrepreneur’s Journey.

    • 1 hr
    Episode 158: Now Hear This: Christian Gormsen on Breaking Convention in the Hearing Industry at Eargo

    Episode 158: Now Hear This: Christian Gormsen on Breaking Convention in the Hearing Industry at Eargo

    Like many entrepreneurs, Christian Gormsen admits he didn’t start his career with a passion for his current field. Instead, he backed into the hearing industry from his work in investment banking and consulting, and eventually wound up working at the world's 4th largest hearing aid company. Christian realized just how stigmatized hearing aids are and became determined to address this. In 2012, he was first connected to Eargo while doing advisory work. Unlike other traditional hearing aids, Eargo’s products are basically invisible, comfortable, rechargeable, removable, and sold directly to consumers rather than via physicians. After being a board member for about 3 years, Christian was asked to lead Eargo as CEO through a challenging time in 2016, and by the end of 2017, he had achieved a four-fold increase in sales and the company has since gone public. In this interview with host Geoff Pardo, Christian shares his story of entering the hearing industry and then joining Eargo, various unique aspects about the company compared to traditional hearing aid manufacturers that have led to their success, achieving cognitive diversity via cultural diversity, and the effect on the company’s personnel after its recent transition to being public.

    • 1 hr 10 min
    Episode 157: Success nVisioned, Surbhi Sarna’s Story

    Episode 157: Success nVisioned, Surbhi Sarna’s Story

    After passing out from extremely painful complex ovarian cists at age 13, Surbhi Sarna became all too familiar with the challenges and lack of adequate solutions for women’s health. Benefiting from intelligent and entrepreneurial parents, she became so determined to start a company to tackle women’s health issues someday that she wrote it in her college application personal statement. After graduating from UC Berkely, she went to Abbott Vascular to work on some of their most innovative products before transitioning to BioCardia for more of a startup culture. While at both places, she continued to read papers about women’s health, and after she lost her grandmother to breast cancer, she decided to take her leap of faith and start nVision Medical. In this interview with host Geoff Pardo, Surbhi shares her story of founding and leading nVision, including securing a very challenging first funding round, transitioning from being an engineer to a woman CEO, negotiating the company’s eventual exit, and staying onboard to support the product’s further development as part of Boston Scientific. Here all this plus Surbhi’s thoughts on the changing landscape of women’s health and what’s next for her.

    • 59 min

Top Podcasts In Business

Listeners Also Subscribed To